|4Dec 5, 5:16 PM ET

Koppel Adam 4

4 · Solid Biosciences Inc. · Filed Dec 5, 2022

Insider Transaction Report

Form 4
Period: 2022-12-02
Koppel Adam
Director
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2022-12-02+2,6662,666 total
    Exercise: $6.77Exp: 2032-12-01Common Stock (2,666 underlying)
Footnotes (1)
  • [F1]This option was granted on December 2, 2022 and vests in full on the one-year anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION